In the Press
October 26, 2021

Licensing Biotech Breakthroughs is a Contentious, Painful Slog. Can the Process be Fixed? (STAT+)

Students, employees, and professors at a research institution generally pledge that in the event they make some interesting, potentially money-making discovery, they'll notify their institution's tech transfer office to ensure the institution and the public will benefit from the intellectual property created under its auspices. For the last year and a half, a group of leading universities, investors, and law firms, including Goodwin, have worked to make the process less agonizing. The group is compiling templates for the kinds of clauses usually found in licensing deals, which any tech transfer officer or venture investor could use as a starting point. Read the STAT+ article here.